CIBC Private Wealth Group
SAGE

CIBC Private Wealth Group’s Sage Therapeutics SAGE Stock Holding History

CIBC Private Wealth Group’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-140
Closed -$819 – 3244
2024
Q4 		$819 Hold
140
– – ﹤0.01% 2813
2024
Q3 		$1.01K Hold
140
– – ﹤0.01% 2909
2024
Q2 		$1.53K Hold
140
– – ﹤0.01% 2813
2024
Q1 		$2.51K Buy
+140
New +$3.23K ﹤0.01% 2697

Other funds holding SAGE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

CIBC Private Wealth Group's SAGE Position: Q1 2025 in Review

CIBC Private Wealth Group sold out of Sage Therapeutics (SAGE) in Q1 2025, closing a stake of 140 shares — an estimated $819 sold.

CIBC Private Wealth Group first reported a position in SAGE in Q1 2024 and held it in 4 quarters. The position peaked at $2.51K in Q1 2024. 198 funds tracked by Wall St. Rank hold SAGE as of Q1 2025.

  • CIBC Private Wealth Group reported no remaining Sage Therapeutics position as of Q1 2025 after selling out during the quarter.
  • CIBC Private Wealth Group sold 140 Sage Therapeutics shares in Q1 2025, an estimated $819.
  • CIBC Private Wealth Group first reported a position in Sage Therapeutics in Q1 2024 and held it in 4 quarters.
  • CIBC Private Wealth Group's Sage Therapeutics position peaked at $2.51K in Q1 2024.
  • 198 funds tracked by Wall St. Rank held Sage Therapeutics as of Q1 2025.

Based on CIBC Private Wealth Group's 13F filing for Q1 2025, filed 14 May 2025.